ANI Pharmaceuticals appoints Renee P. Tannenbaum to Board of Directors

ANI PHARMACEUTICALS INC

Board expanded from 8 to 9 members; Dr. Tannenbaum appointed effective March 19, 2022.
Received initial restricted stock award with $435,000 grant date fair value, vesting over 3 years.
Dr. Tannenbaum brings over 35 years pharma experience; previously at Halozyme, AbbVie, Novartis, BMS, Merck.
Appointment supports commercialization of Purified Cortrophin Gel, according to board chair.
Dr. Tannenbaum determined independent under Nasdaq rules; no committee assignment yet.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Renee P. Tannenbaum

Director

ANIP · ANI PHARMACEUTICALS INC

Effective: 2022-03-19
Filed: March 23, 2022, 7:59 PM ET

On March 19, 2022, the Board of Directors (the “Board”) of ANI Pharmaceuticals, Inc. (the “Company”) increased the size of the Board from eight to nine members and appointed Renee P. Tannenbaum, Pharm.D., a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Renee P. Tannenbaum was appointed as Director at ANI PHARMACEUTICALS INC.

Action: appointed
Role: Director

Exact text from the filing

On March 19, 2022, the Board of Directors (the “Board”) of ANI Pharmaceuticals, Inc. (the “Company”) increased the size of the Board from eight to nine members and appointed Renee P. Tannenbaum, Pharm.D., a director of the Company, effective immediately.

View on SEC.gov

ANI PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-22-037034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.